You searched for prescription-drugs | Page 15 of 179

What Drives Health Spending in the U.S. Compared to Other Countries

Aug 2, 2024

Issue Brief

An updated issue brief looks at the drivers of health spending in the U.S. and key differences between the U.S. and other large, wealthy nations. The analysis finds that people in the U.S. spent $5,683 more per person on health care compared to those in similarly large and wealthy countries. Almost 80% of the difference in spending came from inpatient and outpatient care costs. Many retail prescription drugs also cost more in the U.S. In…

Voters Chose Republicans This Year in Spite of Differences on Health Care

Nov 7, 2024

Quick Insights

Despite [Republicans’] victories, there are signs in the polling that voters are not necessarily aligned with some of the policies Republicans may pursue when it comes to health care.

What the Outcome of the Election Could Mean for Medicaid

Sep 6, 2024

Issue Brief

This brief examines the two presidential candidates’ records and other recent policy proposals that could inform starkly different directions for the program across key areas, including Affordable Care Act (ACA) Medicaid expansion, financing, eligibility, benefits, and cost-sharing, prescription drugs, long-term services and supports, and managed care.

Claims Denials and Appeals in ACA Marketplace Plans in 2024

Mar 24, 2026

Issue Brief

This brief analyzes federal transparency data published by CMS on claims denials and appeals for Marketplace plan offered on HealthCare.gov in 2024, and finds insurers denied 19% of in-network claims. Consumers rarely appeal denied claims.

KFF Follow-Up Survey of Marketplace Enrollees: Following End of Enhanced Credits, Half of Marketplace Enrollees Now Say Costs Are a Lot Higher, Most Expect to Cut Back on Basic Household Expenses to Afford Coverage

Mar 19, 2026

News Release

Following the expiration of the enhanced premium tax credits for people with Affordable Care Act (ACA) Marketplace plans, a new KFF follow-up survey of the same Marketplace enrollees KFF surveyed in 2025 finds half (51%) of returning enrollees say their health care costs are “a lot higher” this year compared to last year, including four in ten who specifically say their premiums are “a lot higher.”

What’s Next for Medicare Negotiated Drug Prices Under the Trump Administration?

Jan 17, 2025

Quick Insights

The Trump Administration could go in one of three directions with the Medicare negotiations program: stay the course, water it down or repeal it all together. There are potential tradeoffs with each, but the first would be most popular.

The Impact of H.R. 1 on Two Medicaid Eligibility Rules

Sep 22, 2025

Issue Brief

This issue brief describes the impact of H.R.1's 10-year delay in implementing provisions in two Medicaid eligibility rules that would have reduced red tape. The delayed rules are projected to decrease federal spending and future Medicaid and CHIP enrollment and increase coverage loss.

Medicare Advantage 2026 Spotlight: A First Look at Plan Premiums and Benefits

Dec 9, 2025

Issue Brief

This brief provides an overview of premiums and benefits in Medicare Advantage plans that are available for 2026 and key trends over time.

Classifying Misoprostol and Mifepristone as Controlled Substances: Implications for the Management of Non-Abortion Related Conditions

Apr 3, 2025

Issue Brief

This data note analyzes employer-sponsored insurance and Medicaid claims data to see how mifepristone and misoprostol—two drugs used in the medication abortion regimen—are prescribed for reasons other than abortion including management of miscarriages, abnormal bleeding or hemorrhage, as well as IUD insertions and other conditions.

KFF Health Tracking Poll: Public Weighs Health Care Spending and Other Priorities for Incoming Administration

Jan 17, 2025

Feature

With the incoming Trump administration and Republican-led Congress looking to ways to reduce federal spending, this Poll finds that the Medicare and Medicaid programs remain broadly popular, and more people favor more spending on those programs than less spending. Among potential actions on health, the public sees price transparency and limiting chemicals in food as top priorities. Few say so about cuts to Medicaid and restrictions on abortion.

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

Search

Filter